HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Doxapram Hydrochloride

HCID 64648
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
7081-53-0
Standard SMILES
CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O.Cl.O
InChIKey
ZOMBFZRWMLIDPX-UHFFFAOYSA-N
Molecular formula
C24H33ClN2O3
Average molar mass
433 g/mol
Monoisotopic mass
432.2179706

Overview

Doxapram Hydrochloride is a peripheral and central respiratory stimulant with a brief duration of action. Doxapram hydrochloride stimulates respiration by an action on chemoreceptors in the carotid arteries and, at increased dosage, stimulates central respiratory centers in the medulla as well as other parts of the brain and spinal cord. This results in an increased tidal volume and a slightly increased respiratory rate. Doxapram hydrochloride may also improve cardiac output probably due to an increased release of catecholamines. This respiratory stimulant is used in postanesthesia respiratory depression.

Names & identifiers

Preferred name
Doxapram Hydrochloride
IUPAC
1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one;hydrate;hydrochloride
English name
Doxapram hydrochloride monohydrate
Molecular formula
C24H30N2O2.ClH.H2O
Molecular weight
432.99

Names & synonyms

Doxapram hydrochloride monohydrateDoxapram HCLStimulexinP5RU6UOQ5YAHR-619NSC-170958NSC-760347DTXCID9027815CHEBI:31520NSC170958RefChem:565601-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-2-pyrrolidinone Monohydrochloride, Monohydrate
Show more names
1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinonehydrochloridehydrDoxapraM HCL APIDoxapram HydrochorideDoxapram hydrochloride CRSDoxapraM Hydrochloride, USPdoxapramhydrochloridehydrateDopram hydrochloride hydrate
Doxapram HydrochlorideDTXSID90478377081-53-0Doxapram hydrochloride hydrate15083-72-4DopramDoxapraM interMediateMFCD09954698

Database identifiers

CAS
7081-53-0
PubChem CID
64648
DTXSID

Properties

Computed structural properties

Topological polar surface area
33.8 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
4
Rotatable bonds
6
Heavy atoms
30
Formal charge
0
Complexity
487

Experimental & physicochemical properties

Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Animal DrugsFDA approved animal drugs -> Active ingredient

Physicochemical properties

Melting point
217 · 217-219°
storage temp.
Sealed in dry,Room Temperature
solubility
Soluble in water, in alcohol and in methylene chloride.
form
Solid
color
White to off-white
Major Application
pharmaceutical (small molecule)
InChI
InChI=1S/C24H30N2O2.ClH.H2O/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21;;/h3-12,22H,2,13-19H2,1H3;1H;1H2
InChIKey
ZOMBFZRWMLIDPX-UHFFFAOYSA-N
SMILES
C1(=O)N(CC)CC(CCN2CCOCC2)C1(C1C=CC=CC=1)C1C=CC=CC=1.Cl.O
FDA UNII
5 RU6UOQ5Y · P5RU6UOQ5Y

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (96.4%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 55 reports by companies from 2 notifications to the ECHA C&L Inventory.

Hazard information

Regulatory InformationDoxapram hydrochloride: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Hazard Classes and CategoriesAcute Tox. 4 (96.4%)

Toxicology

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Doxapram hydrochloride

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Safety data

wgk
WGK 3
ridadr
UN 2811 6.1 / PGIII
hs_code
2934990002
Toxicity
LD50 orally in rats: 261 mg/kg (Goldenthal)
Signal word
Danger
Symbol(GHS)
GHS06
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects

Chemistry & industry

Pharmacology

FDA Pharmacological Classification · 2 items

DOXAPRAM HYDROCHLORIDE

Increased Medullary Respiratory Drive [PE]; Respiratory Stimulant [EPC]

MeSH Pharmacological Classification · 2 items

A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.

Drugs used for their effects on the respiratory system.

Applications · 3 items

DescriptionDoxapram is a central respiratory stimulant. It increases respiration and phrenic nerve activity in anesthetized cats at a dose of 1.0 mg/kg. Doxapram acts through carotid chemoreceptors, lacking activity in anesthetized cats following carotid denervation. Formulations containing doxapram have been used to increase respiration in patients with chronic pulmonary disease, respiratory depression induced by drug overdose, and to stimulate deep breathing post-anesthesia.

Usesantibacterial

General DescriptionDoxapram, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone hydrochloride hydrate (Dopram), has an obscuremolecular mechanism of action. Overall, it stimulatesrespiration by action on peripheral carotid chemoreceptors.It has use as a respiratory stimulant postanesthetically, afterCNS depressant drug overdose, in chronic obstructive pulmonarydiseases, and in the apneas. Dopram is administeredexclusively by intravenous injection. Because of the benzylalcohol content of the injectable formulation, Dopram mustnever be given to neonates.

Upstream & downstream products

Upstream raw materials

Sulfuric acidSodium amide

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
DTXSID60991081
ChEMBL
CHEMBL3989519
UNII
P5RU6UOQ5Y
EC Number
615-173-3
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Excreted unchanged in urine
5 % · <5%
Volume of distribution
0.58 · 0.58-2.74(L/kg)
Biological half-life
2.4 · 2.4-4.1 / -
Symbol(GHS)
6 · GHS06
Signal word
Danger
Hazard statements
301 · H301
Precautionary statements
301 · P301+P330+P331+P310
RIDADR
2811 · UN 2811 6.1 / PGIII
WGK Germany
3 · WGK 3
HS Code
2934990002 · 2934990002
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
3 Oral · Acute Tox. 3 Oral
Toxicity
50 orally · LD50 orally in rats: 261 mg/kg (Goldenthal)
Hazard statements
H301
Hazard Classifications
Acute Tox. 3 Oral
Precautionary statements
P301+P330+P331+P310
1-ethyl-3-chloro-pyrrolidine
Morpholine
Hydrochloric acid
Diphenylacetonitrile

Suppliers100 total

北京华美互利生物化工010-56205725 · [email protected]
南通飞宇生物科技有限公司0513-68819626 15152877458 · [email protected]
Career Henan Chemica Co+86-0371-86658258 +86-13203830695 · [email protected]
武汉敬康恩生物医药科技有限公司13720134139 086-15871494362 13720134139 · [email protected]
艾吉析科技(上海)有限公司17717235263 · [email protected]
上海麦克林生化科技股份有限公司021-50706066 15221275939 · [email protected]
河南赢创生物科技有限公司16650615803 · [email protected]
杭州品高化工有限公司0571-87658025 · [email protected]
上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]
湖北金梭生物科技有限公司00123456789 · [email protected]
湖北海克斯生化有限公司17362916295; 17362916295 · [email protected]
河北展药生物科技有限公司15369953316 +8615369953316 · [email protected]
T&W GROUP021-61551611 13296011611 · [email protected]
Dayang Chem (Hangzhou) Co.,Ltd.+86-0571-88938639 17705817739 · [email protected]
Jai Radhe Sales+(91)-(79)-26431096/65255722 · [email protected]
武汉易泰科技有限公司上海分公司18930552037 · [email protected]
上海波以尔化工有限公司[email protected]
安耐吉化学&3A(安徽泽升科技有限公司)021-58432009 400-005-6266 · [email protected]
梯希爱(上海)化工贸易有限公司021-61109150 · [email protected]
InvivoChem中国13549236410 · [email protected]
MedBio脉铂医药021-69568360 18916172912 · [email protected]
上海里程化工有限公司+86 (21) 5756-1621 · [email protected]
北京博奥森生物技术有限公司400-901-9800 18611424007 · [email protected]
上海泰坦科技股份有限公司4006009262 13023226327 · [email protected]
上海隆盛化工有限公司58099637 13585536065 · [email protected]
佛山宝诺生物科技有限公司0757-85921206 18520245316 · [email protected]
河北茹麒科技有限公司176-03256889 17603256889 · [email protected]
云南西力生物技术股份有限公司0871-65217109 · [email protected]
Abblis Chemicals LLC+1-832-373-8299 · [email protected]
ChemeGen 中国18818260767 · [email protected]
斯百全化学(上海)有限公司021-021-021-67601398-809-809-809 15221380277 · [email protected]
上海遐瑞医药科技有限公司+86 21 61551611
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
深圳康特腾科技有限公司86-0755-86635001 · [email protected]
南京生利德生物科技有限公司025-57798810 18652991625 · [email protected]
南京世洲生物科技有限公司13675144456 · [email protected]
泰州同新生物医药科技有限公司0523-86818997 18652728585 · [email protected]
四川省维克奇生物科技有限公司028-81700200 18116577057 · [email protected]
雷丁试剂0510-85629785 18013409632 · [email protected]
湖南华腾制药有限公司400-8592883 15367835770 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
上海寰川实业有限公司021-61478794 · [email protected]
上海永叶生物科技有限公司86-021-61559134 15921386130 · [email protected]
武汉贝乐叶生物医药科技有限公司18086118078 · [email protected]
深圳振强药物研发有限公司+86-0755-66853366 +86-13670046396 · [email protected]
珠海安哲生物科技有限公司13169972583 · [email protected]
TargetMol中国(陶术生物)021-021-33632979 15002134094 · [email protected]
武汉德拜技术有限公司18086626237 18086626237 · [email protected]
BOC Sciences16314854226; +8616314854226 · [email protected]
成都凯泰创医药科技有限公司16608035117 · [email protected]
Additional notes · 1 item

DefinitionChEBI: The monohydrate form of doxapram hydrochloride. A central and respiratory stimulant with a brief duration of action, it is used as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, nd of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.